Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients-Reference-Cited by-同舟云学术

Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients

Published:2023-03 Issue:3 Volume:61 Page:2202009
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Asmus Erik,Karle Weronika,Brack Markus C.,Wittig Corey,Behrens Felix,Reinshagen Leander,Pfeiffer Moritz,Schulz Sabrina,Mandzimba-Maloko Bertina,Erfinanda Lasti^ORCID,Perret Paul L.,Michalick Laura,Smeele Patrick J.,Lim Endry H.T.^ORCID,van den Brom Charissa E.^ORCID,Vonk Alexander B.A.,Kaiser Toralf,Suttorp Norbert,Hippenstiel Stefan,Sander Leif E.,Kurth Florian^ORCID,Rauch Ursula,Landmesser Ulf,Haghikia Arash^ORCID,Preissner Robert,Bogaard Harm J.,Witzenrath Martin,Kuebler Wolfgang M.,Szulcek Robert,Simmons Szandor

Funder

Berlin Institute of Health

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

Deutsche Stiftung für Herzforschung

Deutsches Zentrum für Herz-Kreislaufforschung

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation

2. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation

3. Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation;Erfinanda;Sci Transl Med,2022

4. Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension

5. CFTR therapeutics normalize cerebral perfusion deficits in mouse models of heart failure and subarachnoid hemorrhage;Lidington;JACC Basic Transl Sci,2019